Purchase Order 75F40122P00116
- Not listed
- This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific Inc. The contract is for the delivery of a genetic analyzer with a 4-year post-warranty maintenance option, with a ceiling value of $80,335.95 and a completion date of September 14, 2025. Life Technologies Corporation is a leading provider of biomedical research and genetic analysis tools and technologies to government agencies and...
- This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific Inc. The contract, valued at $186,112.65, is for the provision of AB 7500 FAST PM SERVICE AGREEMENT to support the FDA's mission and activities. Life Technologies Corporation is a leading provider of biomedical research and genetic analysis tools, specializing in the delivery of scientific products, including specialized...
- The U.S. Food and Drug Administration awarded a firm fixed-price purchase order valued at $54,160.60 to Life Technologies Corporation (doing business as Thermo Fisher Scientific) on April 1, 2022, for a service and qualification agreement covering a 7500 FAST Real Time PCR System (Serial Number 275015685). The contract, which carries no set-aside designation, specifies performance in Atlanta, Georgia, with an ultimate completion date of March 31, 2027. Life Technologies Corporation, a leading...
- This is a firm fixed-price purchase order awarded to Life Technologies Corporation, doing business as Thermo Fisher Scientific, to provide maintenance services for the ABI 7500 FAST Real-Time PCR System. The $232,357.32 contract was awarded on September 9, 2025, with an ultimate completion date of September 9, 2030. The funding agency is the Food and Drug Administration (FDA), a civilian agency. The contract is not set aside for any specific business type. Life Technologies Corporation is a...
- This federal contract award is for REAL TIME PCR ACCESSORIES valued at $20,923.80. The contract was awarded by the Food and Drug Administration (FDA), a civilian agency, to the prime contractor Life Technologies Corporation, doing business as Thermo Fisher Scientific. Life Technologies is a prominent manufacturer of scientific instruments, reagents, and consumables that provides specialized biotechnology products and services to federal agencies. The contract is a firm fixed price purchase order...
- This federal contract award, valued at $80,606.37, was issued by the Food and Drug Administration (FDA) to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific, to procure a live cell imaging system. The contract is a firm fixed-price purchase order with a completion date of September 29, 2023. The contract does not involve any set-aside designation. Life Technologies Corporation is a leading provider of biomedical research and genetic analysis tools and technologies, and...
- The Food and Drug Administration awarded a $15,682.41 firm fixed-price purchase order to Life Technologies Corporation (doing business as Thermo Fisher Scientific) on July 15, 2019, for a Fast Real Time PCR Systems Service Agreement. The contract, with an ultimate completion date of August 14, 2020, was performed in Carlsbad, California, and involved no set-aside designation. Life Technologies Corporation, a leading manufacturer of scientific instruments and biotechnology products, supplies...
- This $17,980 firm fixed-price federal contract was awarded by the Office of the Director, a civilian U.S. government agency, to Life Technologies Corporation, doing business as Thermo Fisher Scientific. The contract, which was not set-aside, is a Blanket Purchase Agreement (BPA) call order. Life Technologies Corporation is a prominent manufacturer of scientific instruments, reagents, and consumables that provides specialized biotechnology products and services to federal agencies. The contract...
- This is a purchase order contract awarded by the Food and Drug Administration (FDA) to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific Inc. The contract is for the purchase of a Quant Studio 7 Pro system, with a ceiling value of $73,475.40 and a completion date of October 31, 2022. The contract is a firm fixed-price purchase order and does not involve any set-aside designation. Life Technologies Corporation is a leading provider of biomedical research and genetic analysis...
- The U.S. Food and Drug Administration (FDA) awarded a $76,772.10 firm fixed-price purchase order to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific, for an ABI 7500 Fast Real-Time PCR Instrument. This sole-source award was made under FAR 6.302-1, FAR 13.106(b), and FAR 5.203, as the FDA determined that only Life Technologies could provide the required system. The award does not have a set-aside designation. As a manufacturer of scientific instruments, reagents, and...
This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific Inc. The contract is valued at $153,142.00 and runs through June 6, 2027. The contract is for Life Technologies to perform molecular analyses of bacteria isolated from regulatory samples using the ABI7500 Fast Real-Time PCR system. This specialized laboratory equipment is critical for the FDA's Office of Regulatory Affairs (ORA) microbiology laboratories to rapidly identify high-risk pathogens. The contract does not have a set-aside designation. Life Technologies Corporation is the prime contractor, and its parent company, Thermo Electron Corporation, has a broader history of providing scientific instruments and services to various federal agencies, including the Department of Health and Human Services, Department of Defense, and Environmental Protection Agency.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
PM- ABI7500 Fast Real Time PCR systems Plus 4 Options | 1253311 | Department of Health and Human Services Food and Drug Administration Office of Acquisition and Grant Services | Special Notice 1/1 | 4/20/22, 10:08 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00006 | Exercise an Option | $31.5k | 6/5/25 | |
| P00005 | Other Administrative Action | $0 | 10/30/24 | |
| P00004 | Exercise an Option | $30.6k | 4/25/24 | |
| P00003 | Other Administrative Action | $0 | 3/16/23 | |
| P00002 | Exercise an Option | $29.7k | 3/12/23 |